SLC18A3, solute carrier family 18 member A3, 6572

N. diseases: 117; N. variants: 3
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1057517665
rs1057517665
Entrez Id: 1103;6572
Gene Symbol: CHAT;SLC18A3
CHAT;SLC18A3
CUI: C4310654
Disease:
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC
0.800 GeneticVariation UNIPROT
dbSNP: rs1057517665
rs1057517665
Entrez Id: 1103;6572
Gene Symbol: CHAT;SLC18A3
CHAT;SLC18A3
CUI: C4310654
Disease:
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC
C 0.800 CausalMutation CLINVAR
dbSNP: rs1057517666
rs1057517666
Entrez Id: 1103;6572
Gene Symbol: CHAT;SLC18A3
CHAT;SLC18A3
CUI: C4310654
Disease:
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC
0.800 GeneticVariation UNIPROT
dbSNP: rs1057517666
rs1057517666
Entrez Id: 1103;6572
Gene Symbol: CHAT;SLC18A3
CHAT;SLC18A3
CUI: C4310654
Disease:
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC
C 0.800 CausalMutation CLINVAR
dbSNP: rs733722
rs733722
Entrez Id: 1103;6572
Gene Symbol: CHAT;SLC18A3
CHAT;SLC18A3
CUI: C0002395
Disease:
Alzheimer's Disease
0.010 GeneticVariation BEFREE After correction for multiple testing, we found one SNP, rs733722, in a promoter region of CHAT, is associated with response of AD patients to cholinesterase inhibitors (P = 0.03) and accounts for 6% of the variance in response to AChE inhibitors. 16424819 2006